Australia markets close in 53 minutes

The Hydration Pharmaceuticals Company Limited (HPC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0130+0.0010 (+8.33%)
As of 12:14PM AEST. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) 3.18M
Enterprise value 6.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.21
Price/book (mrq)1.87
Enterprise value/revenue 0.63
Enterprise value/EBITDA -0.85

Trading information

Stock price history

Beta (5Y monthly) 1.74
52-week change 3-81.24%
S&P500 52-week change 323.10%
52-week high 30.0659
52-week low 30.0120
50-day moving average 30.0145
200-day moving average 30.0282

Share statistics

Avg vol (3-month) 349.26k
Avg vol (10-day) 374.72k
Shares outstanding 5265.14M
Implied shares outstanding 6265.14M
Float 8145.8M
% held by insiders 130.63%
% held by institutions 126.66%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -80.69%
Operating margin (ttm)-79.15%

Management effectiveness

Return on assets (ttm)-56.65%
Return on equity (ttm)-447.28%

Income statement

Revenue (ttm)10.04M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)-4.70%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-8.1M
Diluted EPS (ttm)-0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.84M
Total cash per share (mrq)0.01
Total debt (mrq)3.89M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.13
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-5.73M
Levered free cash flow (ttm)-2.9M